Label: Information for the User
DURVITAN 300 mg
Extended-Release Hard Capsules
(Caffeine)
Read the entire label carefully as it contains important information for you.
Caffeine has a stimulating effect on the nervous system.
It is indicated for the relief of occasional and transient feelings of weakness or physical fatigue.
Do not take Durvitan 300 mg
In severe liver, heart, stomach ulcer, duodenum, or high blood pressure alterations.
Inform your doctor or pharmacist if you are using or have recently used any other medication, including those purchased without a prescription.
Particularly, if you are using some of the following medications, it may be necessary to modify the dose of some of them or even interrupt treatment:
Interference with diagnostic tests:
If you are to undergo any diagnostic test (blood or urine analysis, ...), inform your doctor that you are taking this medication, as it may alter the results of these tests.
Additionally, diabetic patients should be aware that caffeine can increase blood glucose levels.
Taking Durvitan 300 mg with food and drinks.
Limit the consumption of caffeine-containing beverages (coffee, tea, chocolate, and cola drinks) while taking this medication.
Consult your doctor or pharmacist before using any medication.
Important for women If you are pregnant or think you may be, consult your doctor before taking this medication. The consumption of medications during pregnancy can be dangerous for the embryo or fetus and should be monitored by your doctor. |
Lactation
Consult your doctor or pharmacist before using any medication.
Avoid taking Durvitan 300 mg, as, although caffeine passes into breast milk in small amounts (around 1%), it can accumulate in the infant.
Use in children
Do not use this medication in children under 12 years old.
Driving and operating machinery
No effects on the ability to drive and operate machinery have been described at the recommended doses.
Important information about some of the components of Durvitan 300 mg
This medication contains saccharose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow these instructions unless your doctor has given you different ones. Consult your doctor or pharmacist if you have any doubts.
The patient should be aware that there are other sources of caffeine (coffee, tea, chocolate, cola soft drinks) that can produce a similar effect to this medication. Therefore, it is recommended to moderate the consumption of these beverages while taking Durvitan 300 mg.
Oral administration.
Swallow 1 capsule with water or food. If necessary, up to 3 capsules can be taken per day, spacing the intake of each capsule at least 6 hours apart.
Do not take the last dose within 6 hours of bedtime to avoid insomnia.
Do not take more than 3 capsules per day, divided into several doses.
If you observe that the symptoms worsen, or if they persist for more than 7 days, you should consult your doctor.
If you take more Durvitan 300 mg than you should:
If you have taken Durvitan 300 mg in excess, consult your doctor or pharmacist immediately.
The symptoms of overdose are characterized by a first phase of excitement, followed by dizziness, vomiting, diarrhea, abdominal pain, and seizures. The treatment of overdose is more effective if it is performed within the first 4 hours after ingestion of this medication.
In case of overdose or accidental ingestion, visit your doctor or call the Toxicological Information Service (phone: 91.5620420), indicating the medication and the amount ingested.
Like all medications, Durvitan 300 mg may have adverse effects, although not all people may experience them.
Very frequently (in more than 1 in 10 patients), the following may occur: insomnia, restlessness, and excitement.
Frequently (in less than 1 in 10 but more than 1 in 100 patients), the following may occur: nausea, vomiting, diarrhea, stomach pain, headache, tinnitus, disorientation, heart rhythm disturbances, irritability, hot flashes, rapid breathing, and very abundant urine elimination.
At high doses, anxiety and anguish may appear.
In some cases, it may also cause hyperglycemia or hypoglycemia (elevated or decreased blood glucose).
Treatment should be immediately suspended if the patient experiences any episode of dizziness or palpitations.
If you consider that any of the adverse effects you are experiencing are severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
Keep out of the reach and sight of children.
No special storage conditions are required.
Expiration Date
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through the drains or in the trash. Ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Durvitan 300 mg
Appearance of the product and contents of the package
They are prolonged-release hard capsules.
They are presented in boxes containing 1 blister with 10 prolonged-release hard capsules.
Holder of the marketing authorization
Pharmaceutical Notes, S.L. Carretera de Sant Cugat to Rubí, km1 1.
08174 Sant Cugat del Vallés. Barcelona (Spain)
Responsible for manufacturing
Sincrofarm, S.L.
C/ Mercurio, 10. Pol. Ind. Almeda
08940 - Cornellá de Llobregat. Barcelona (Spain).
This leaflet was approved in: April 2007
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.